Turnover: ()
Country: Belgium
- TheraVet® is a Belgian veterinary biotechnology company founded in 2017, specializing in osteoarticular treatments for companion animals such as dogs and cats primarily, but also horses.
- The Company develops targeted treatments aimed at improving the quality of life of pets suffering from osteoarticular diseases.
- TheraVet works closely with Key Opinion Leaders in Europe and the United States to meet the growing needs of veterinary medicine.
News
With this new agreement with the distributor Vetpharma, Theravet's Biocera Vet products are available worldwide 21/02/2023
- Young Belgian veterinary biotechnology company specializing in the development of osteoarticular treatments for companion animals
- This exclusive agreement will enable TheraVet to market its Biocera-Vet product range on all five continents
- Expected average annual sales growth of 13.1% over the period 2022 to 2027 for the animal health market